
Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Resistant Starch Type 2 is a prebiotic fiber found in uncooked potatoes, green bananas, and high-amylose corn that resists digestion in the small intestine. It ferments in the colon to produce short-chain fatty acids like butyrate, which enhance insulin sensitivity and feed beneficial gut bacteria.

Reported Benefits (Provisional)
Origin & History

Resistant Starch (Type 2) is a form of starch that resists digestion in the small intestine. It is found naturally in raw potatoes and unripe bananas and can be isolated for supplements.
Research Narrative (Provisional)
RCTs have demonstrated Resistant Starch's benefits in gut health and insulin sensitivity. Meta-analyses confirm its role in supporting metabolic health.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Resistant to digestion, acting as a prebiotic fiber. - Found in raw potatoes, unripe bananas, and legumes. - Produces short-chain fatty acids upon fermentation in the colon.
Reported Mechanism (Provisional)
Resistant Starch Type 2 bypasses small intestine digestion due to its crystalline granule structure and reaches the colon intact. Beneficial bacteria like Bifidobacteria and Bacteroides ferment it into short-chain fatty acids, particularly butyrate, acetate, and propionate. These SCFAs activate GPR41 and GPR43 receptors, improving glucose metabolism through enhanced GLP-1 secretion and reducing inflammation via NF-κB pathway inhibition.
Clinical Narrative (Provisional)
Human studies using 15-30g daily of resistant starch type 2 show 33-50% improvements in insulin sensitivity within 4 weeks. A 12-week randomized controlled trial with 20 participants demonstrated significant increases in Bifidobacteria populations and butyrate-producing bacteria. Meta-analyses indicate modest but consistent reductions in postprandial glucose spikes of 20-30%. However, most studies are small-scale with fewer than 50 participants, requiring larger trials for definitive conclusions.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.







